43 related articles for article (PubMed ID: 10632924)
1. Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.
He M; Zuo C; Wang J; Liu J; Jiao B; Zheng J; Cai Z
Neuro Oncol; 2013 Jun; 15(6):727-34. PubMed ID: 23482670
[TBL] [Abstract][Full Text] [Related]
2. A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma.
Liu Y; Zhang H; Zhao S; Zhang Y
Clin Transl Oncol; 2024 May; ():. PubMed ID: 38773060
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological analysis of diffuse large B-cell lymphoma using molecular biomarkers: a retrospective analysis from 7 Hungarian centers.
Balikó A; Szakács Z; Kajtár B; Ritter Z; Gyenesei A; Farkas N; Kereskai L; Vályi-Nagy I; Alizadeh H; Pajor L
Front Oncol; 2023; 13():1224733. PubMed ID: 37746254
[TBL] [Abstract][Full Text] [Related]
4. Identification of
Xiang X; Gao LM; Zhang Y; Tang Y; Zhao S; Liu W; Ye Y; Zhang W
Front Genet; 2022; 13():849422. PubMed ID: 35711924
[TBL] [Abstract][Full Text] [Related]
5. Probability calibration-based prediction of recurrence rate in patients with diffuse large B-cell lymphoma.
Fan S; Zhao Z; Zhang Y; Yu H; Zheng C; Huang X; Yang Z; Xing M; Lu Q; Luo Y
BioData Min; 2021 Aug; 14(1):38. PubMed ID: 34389029
[TBL] [Abstract][Full Text] [Related]
6. Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL.
Fan S; Zhao Z; Yu H; Wang L; Zheng C; Huang X; Yang Z; Xing M; Lu Q; Luo Y
BMC Med Inform Decis Mak; 2021 Jan; 21(1):14. PubMed ID: 33413321
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological features of parotid lymphoma.
Wang J; Li R; Wang Q; Chen Y; Gao T; Han R; Li N; Zhang K
Int J Clin Exp Pathol; 2020; 13(8):2050-2057. PubMed ID: 32922600
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma of the female genital tract: a clinicopatholngical analysis of 25 cases.
Wang J; Zeng L; Chen S; Wu Q; Ma L; Wu S; Wang ZP; Tao Y; Chai D
Am J Transl Res; 2019; 11(9):5800-5811. PubMed ID: 31632549
[TBL] [Abstract][Full Text] [Related]
9. An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy.
Szablewski V; Bret C; Kassambara A; Devin J; Cartron G; Costes-Martineau V; Moreaux J
Oncotarget; 2018 Apr; 9(27):19079-19099. PubMed ID: 29721185
[TBL] [Abstract][Full Text] [Related]
10. Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart.
Zamani-Ahmadmahmudi M; Aghasharif S; Ilbeigi K
BMC Vet Res; 2017 Jan; 13(1):17. PubMed ID: 28069005
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Bcl-2 and p53 Protein Expressions and Ki67 Proliferative Index in Diffuse Large B-cell Lymphoma.
Küçükzeybek BB; Bener S; Çallı AO; Paksoy TD; Payzin B
Turk J Haematol; 2013 Sep; 30(3):275-82. PubMed ID: 24385807
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of Thioredoxin-1 mediates growth, survival, and chemoresistance and is a druggable target in diffuse large B-cell lymphoma.
Li C; Thompson MA; Tamayo AT; Zuo Z; Lee J; Vega F; Ford RJ; Pham LV
Oncotarget; 2012 Mar; 3(3):314-26. PubMed ID: 22447839
[TBL] [Abstract][Full Text] [Related]
13. Quantitative image analysis in the assessment of diffuse large B-cell lymphoma.
Chabot-Richards DS; Martin DR; Myers OB; Czuchlewski DR; Hunt KE
Mod Pathol; 2011 Dec; 24(12):1598-605. PubMed ID: 21841768
[TBL] [Abstract][Full Text] [Related]
14. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.
Miles RR; Raphael M; McCarthy K; Wotherspoon A; Lones MA; Terrier-Lacombe MJ; Patte C; Gerrard M; Auperin A; Sposto R; Davenport V; Cairo MS; Perkins SL;
Pediatr Blood Cancer; 2008 Sep; 51(3):369-74. PubMed ID: 18493992
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 splice variant and risk for non-Hodgkin lymphoma.
Wang SS; Cozen W; Severson RK; Hartge P; Cerhan JR; Davis S; Welch R; Rothman N; Chanock SJ
Hum Genet; 2006 Sep; 120(2):297-300. PubMed ID: 16783567
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of nodal diffuse large B cell lymphoma by immunohistochemical profiles with emphasis on CD138 expression as a poor prognostic factor.
Oh YH; Park CK
J Korean Med Sci; 2006 Jun; 21(3):397-405. PubMed ID: 16778379
[TBL] [Abstract][Full Text] [Related]
17. Pediatric non-Hodgkin's lymphoma: clinical and biologic prognostic factors and risk allocation.
Weitzman S; Suryanarayan K; Weinstein HJ
Curr Oncol Rep; 2002 Mar; 4(2):107-13. PubMed ID: 11822982
[TBL] [Abstract][Full Text] [Related]
18. Prognostic clinicopathologic factors, including immunologic expression in diffuse large B-cell lymphomas.
Zhang A; Ohshima K; Sato K; Kanda M; Suzumiya J; Shimazaki K; Kawasaki C; Kikuchi M
Pathol Int; 1999 Dec; 49(12):1043-52. PubMed ID: 10632924
[TBL] [Abstract][Full Text] [Related]
19. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
Lossos IS; Jones CD; Warnke R; Natkunam Y; Kaizer H; Zehnder JL; Tibshirani R; Levy R
Blood; 2001 Aug; 98(4):945-51. PubMed ID: 11493437
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
